Numerous studies have shown that NF-κB may accelerate the progression of DKD by regulating inflammation; for example, it has been shown that NF-κB mediates high-glucose-induced inflammatory response and ECM accumulation in glomerular mesangial cells (Chen et al., 2016; Liu et al., 2019). Here, NFKB1 is linked to diabetic kidney disease.